Adjuvant Therapy for Cutaneous Melanoma

被引：1

作者：

Schuitevoerder, Darryl ^{[1
]}

Vining, Charles C. ^{[1
]}

Tseng, Jennifer ^{[1
]}

机构：

[1] Univ Chicago, Dept Surg, 5841 South Maryland Ave MC5094, Chicago, IL 60637 USA

来源：

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2020年 / 29卷 / 03期

关键词：

Melanoma; Adjuvant therapy; Immunotherapy; Targeted therapy; BRAF; MEK; DABRAFENIB PLUS TRAMETINIB; RANDOMIZED PHASE-III; HIGH-RISK MELANOMA; ADVANCED BRAF(V600)-MUTANT MELANOMA; HIGH-DOSE INTERFERON-ALPHA-2B; COOPERATIVE-ONCOLOGY-GROUP; LYMPH-NODE DISSECTION; RESECTED STAGE-III; METASTATIC MELANOMA; OPEN-LABEL;

D O I：

10.1016/j.soc.2020.02.009

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This article presents the current data supporting adjuvant therapy for patients with cutaneous melanoma. With the recent development of novel immunotherapy agents as well as targeted therapy, there are strong data to support the use of these therapies in patients at high risk of developing recurrent or metastatic disease.

引用

页码：455 / +

页数：12

共 64 条

[1] Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697) [J].

Agarwala, Sanjiv S. ;

Lee, Sandra J. ;

Yip, Waiki ;

Rao, Uma N. ;

Tarhini, Ahmad A. ;

Cohen, Gary I. ;

Reintgen, Douglas S. ;

Evans, Terry L. ;

Brell, Joanna M. ;

Albertini, Mark R. ;

Atkins, Michael B. ;

Dakhil, Shaker R. ;

Conry, Robert M. ;

Sosman, Jeffrey A. ;

Flaherty, Lawrence E. ;

Sondak, Vernon K. ;

Carson, William E. ;

Smylie, Michael G. ;

Pappo, Alberto S. ;

Kefford, Richard F. ;

Kirkwood, John M. .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (08) :885-U123

[2] The Benefits of Adjuvant. Radiation Therapy After Therapeutic Lymphadenectomy for Clinically Advanced, High-Risk, Lymph Node-Metastatic Melanoma [J].

Agrawal, Shefali ;

Kane, John M., III ;

Guadagnolo, Beverly A. ;

Kraybill, William G. ;

Ballo, Matthew T. .

CANCER, 2009, 115 (24) :5836-5844

[3] Genomic Classification of Cutaneous Melanoma [J].

Akbani, Rehan ;

Akdemir, Kadir C. ;

Aksoy, B. Arman ;

Albert, Monique ;

Ally, Adrian ;

Amin, Samirkumar B. ;

Arachchi, Harindra ;

Arora, Arshi ;

Auman, J. Todd ;

Ayala, Brenda ;

Baboud, Julien ;

Balasundaram, Miruna ;

Balu, Saianand ;

Barnabas, Nandita ;

Bartlett, John ;

Bartlett, Pam ;

Bastian, Boris C. ;

Baylin, Stephen B. ;

Behera, Madhusmita ;

Belyaev, Dmitry ;

Benz, Christopher ;

Bernard, Brady ;

Beroukhim, Rameen ;

Bir, Natalie ;

Black, Aaron D. ;

Bodenheimer, Tom ;

Boice, Lori ;

Boland, Genevieve M. ;

Bono, Riccardo ;

Bootwalla, Moiz S. ;

Bosenberg, Marcus ;

Bowen, Jay ;

Bowlby, Reanne ;

Bristow, Christopher A. ;

Brockway-Lunardi, Laura ;

Brooks, Denise ;

Brzezinski, Jakub ;

Bshara, Wiam ;

Buda, Elizabeth ;

Burns, William R. ;

Butterfield, Yaron S. N. ;

Button, Michael ;

Calderone, Tiffany ;

Cappellini, Giancarlo Antonini ;

Carter, Candace ;

Carter, Scott L. ;

Cherney, Lynn ;

Cherniack, Andrew D. ;

Chevalier, Aaron ;

Chin, Lynda .

CELL, 2015, 161 (07) :1681-1696

[4] Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma [J].

Amaria, Rodabe N. ;

Reddy, Sangeetha M. ;

Tawbi, Hussein A. ;

Davies, Michael A. ;

Ross, Merrick, I ;

Glitza, Isabella C. ;

Cormier, Janice N. ;

Lewis, Carol ;

Hwu, Wen-Jen ;

Hanna, Ehab ;

Diab, Adi ;

Wong, Michael K. ;

Royal, Richard ;

Gross, Neil ;

Weber, Randal ;

Lai, Stephen Y. ;

Ehlers, Richard ;

Blando, Jorge ;

Milton, Denai R. ;

Woodman, Scott ;

Kageyama, Robin ;

Wells, Daniel K. ;

Hwu, Patrick ;

Patel, Sapna P. ;

Lucci, Anthony ;

Hessel, Amy ;

Lee, Jeffrey E. ;

Gershenwald, Jeffrey ;

Simpson, Lauren ;

Burton, Elizabeth M. ;

Posada, Liberty ;

Haydu, Lauren ;

Wang, Linghua ;

Zhang, Shaojun ;

Lazar, Alexanderj ;

Hudgens, Courtney W. ;

Gopalakrishnan, Vancheswaran ;

Reuben, Alexandre ;

Andrews, Miles C. ;

Spencer, Christine N. ;

Prieto, Victor ;

Sharma, Padmanee ;

Allison, James ;

Tetzlaff, Michael T. ;

Wargo, Jennifer A. .

NATURE MEDICINE, 2018, 24 (11) :1649-+

[5] Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial [J].

Amaria, Rodabe N. ;

Prieto, Peter A. ;

Tetzlaff, Michael T. ;

Reuben, Alexandre ;

Andrews, Miles C. ;

Ross, Merrick J. ;

Glitza, Isabella C. ;

Cormier, Janice ;

Hwu, Wen-Jen ;

Tawbi, Hussein A. ;

Patel, Sapna P. ;

Lee, Jeffrey E. ;

Gersbenwaid, Jeffrey E. ;

Spencer, Christine N. ;

Gopalakrishnan, Vancheswaran ;

Bassett, Roland ;

Simpson, Lauren ;

Mouton, Rosalind ;

Hudgens, Courtney W. ;

Zhao, Li ;

Zhu, Haifeng ;

Cooper, Zachary A. ;

Wani, Khalida ;

Lazar, Alexander ;

Hwu, Patrick ;

Diab, Adi ;

Wong, Michael K. ;

McQuade, Jennifer L. ;

Royal, Richard ;

Lucci, Anthony ;

Burton, Elizabeth M. ;

Reddy, Sangeetha ;

Sharma, Padmanee ;

Allison, James ;

Futreal, Phillip A. ;

Woodman, Scott E. ;

Davies, Michael A. ;

Wargo, Jennifer A. .

LANCET ONCOLOGY, 2018, 19 (02) :181-193

[6] Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial [J].

Ascierto, Paolo A. ;

McArthur, Grant A. ;

Dreno, Brigitte ;

Atkinson, Victoria ;

Liszkay, Gabrielle ;

Di Giacomo, Anna Maria ;

Mandala, Mario ;

Demidov, Lev ;

Stroyakovskiy, Daniil ;

Thomas, Luc ;

de la Cruz-Merino, Luis ;

Dutriaux, Caroline ;

Garbe, Claus ;

Yan, Yibing ;

Wongchenko, Matthew ;

Chang, Ilsung ;

Hsu, Jessie J. ;

Koralek, Daniel O. ;

Rooney, Isabelle ;

Ribas, Antoni ;

Larkin, James .

LANCET ONCOLOGY, 2016, 17 (09) :1248-1260

[7] Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas [J].

Balch, CM ;

Soong, S ;

Smith, T ;

Ross, MI ;

Urist, MM ;

Karakousis, CP ;

Temple, WJ ;

Mihm, MC ;

Barnhill, RL ;

Jewell, WR ;

Wanebo, HJ ;

Desmond, R .

ANNALS OF SURGICAL ONCOLOGY, 2001, 8 (02) :101-108

[8] Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma [J].

Blank, Christian U. ;

Rozeman, Elisa A. ;

Fanchi, Lorenzo F. ;

Sikorska, Karolina ;

van de Wiel, Bart ;

Kvistborg, Pia ;

Krijgsman, Oscar ;

van den Braber, Marlous ;

Philips, Daisy ;

Broeks, Annegien ;

van Thienen, Johannes, V ;

Mallo, Henk A. ;

Adriaansz, Sandra ;

ter Meulens, Sylvia ;

Pronk, Loes M. ;

Grijpink-Ongering, Lindsay G. ;

Bruining, Annemarie ;

Gittelman, Rachel M. ;

Warren, Sarah ;

van Tinteren, Harm ;

Peeper, Daniel S. ;

Haanen, John B. A. G. ;

van Akkooi, Alexander C. J. ;

Schumacher, Ton N. .

NATURE MEDICINE, 2018, 24 (11) :1655-+

[9] Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAFV600 mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis [J].

Blank, Christian U. ;

Larkin, James ;

Arance, Ana M. ;

Hauschild, Axel ;

Queirolo, Paola ;

Del Vecchio, Michele ;

Ascierto, Paolo A. ;

Krajsova, Ivana ;

Schachter, Jacob ;

Neyns, Bart ;

Garbe, Claus ;

Sileni, Vanna Chiarion ;

Mandala, Mario ;

Gogas, Helen ;

Espinosa, Enrique ;

Hospers, Geke A. P. ;

Miller, Wilson H., Jr. ;

Robson, Susan ;

Makrutzki, Martina ;

Antic, Vladan ;

Brown, Michael P. .

EUROPEAN JOURNAL OF CANCER, 2017, 79 :176-184

[10] Effect of long-term adjuvant therapy with interferon alpha-2a in patients with regional node metastases from cutaneous melanoma: a randomised trial [J].

Cascinelli, N ;

Belli, F ;

MacKie, RM ;

Santinami, M ;

Bufalino, R ;

Morabito, A .

LANCET, 2001, 358 (9285) :866-869

← 1 2 3 4 5 6 7 →